Matthias Aizenberg

Navigating the intricate world of clinical trials presents significant challenges for healthcare professionals, with a staggering 61% of U.S.-based doctors finding it difficult to identify and access suitable trials. This issue, rooted in inadequate support tools and a fragmented referral process,

Hereditary angioedema (HAE) presents a persistent challenge in the medical world, primarily due to its unpredictable nature and the severe discomfort it causes through spontaneous swelling. This condition stems from genetic factors, leading to fluid accumulation facilitated by bradykinin release.

Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that many diseases overlap and present similar symptoms, making it difficult to accurately differentiate them. Enter nanomaterials with their unique properties, offering a revolutionary approach to treating

In a significant development for cardiac care, Kerendia, a drug crafted by Bayer, has recently gained FDA approval to treat heart failure patients classified with moderate ejection fraction, defined as having a left ventricular ejection fraction (LVEF) of at least 40%. This approval potentially

In a landscape where healthcare providers strive for excellence, Hartford HealthCare (HHC) has distinguished itself by earning the 2025 AHA Quest for Quality Prize from the American Hospital Association. This accolade marks a significant achievement, underscoring their exceptional leadership,

In today's interview, we dive into the fascinating world of neuroscience with Ivan Kairatov, a leading expert in biopharma with extensive experience in research and development. The discussion centers on understanding the concept of the "brain age gap" and its role in cognitive impairment. Through

Amid rising prevalence and societal impact, addressing Alzheimer's disease demands breakthroughs in research and treatment. The pioneering initiative by the Indiana University School of Medicine, through the TREAT-AD (Target Enablement to Accelerate Therapy Development for Alzheimer's Disease) drug

In a rapidly evolving healthcare landscape, the introduction of the Medicare CY 2026 Payment Rule is expected to reshape various aspects of the industry, particularly focusing on chronic care management and telehealth services. This rule brings both opportunities and challenges, forcing healthcare

Amid growing health crises and increasing global competition in pharmaceuticals, a novel FDA initiative aims to fast-track drug reviews by slashing approval times for essential medicines. Can this new approach significantly impact domestic drug manufacturing, or does it introduce unprecedented

The healthcare landscape is poised to undergo a seismic shift with the introduction of AI-enhanced whole-body MRI technology, promising to revolutionize preventive health screening. CoreViva, a pioneering diagnostic imaging clinic located in Newport Beach, California, is at the forefront of this